TPG.
TPG's India book realised cash on three fronts in eighteen months (Sai Life Sciences, RR Kabel and the Shriram insurance JVs all fully exited), then rode Manipal Hospitals to India's largest-ever healthcare IPO in August 2026, even as Fractal Analytics, the one AI-services bet that has actually listed, priced at a single-digit IRR.
GW GP Score
TPG has run continuously in India since its 2004 debut in Matrix Laboratories, and Puneet Bhatia, Co-Managing Partner of TPG Capital Asia and the country's longest-serving PE head, with board seats across Manipal, Jana, RR Kabel, Sai Life/Sai Pharma and Shriram Capital, has led every vintage since. The book pairs a legacy control buyout (Manipal Health Enterprises, cut from an original TPG Asia VI stake to 11% in TPG Asia VIII after Temasek paid roughly $2bn for a 41% slice in April 2023, then listed in August 2026 at a ₹77,607 Cr valuation, nearly double the 2023 mark) with newer buy-and-build platforms (Altimetrik's 60% majority, now consolidating SLK Software in a ~$600M bolt-on) and TPG Rise Climate-labelled infrastructure (the July 2026 100% buyout of Aseem Infrastructure Finance with GIC and ICICI Bank, and the up-to-$1bn TCS HyperVault AI-data-centre JV signed November 2025). Two older trophy stakes sit alongside these with no governance rights attached: a passive 0.93% of Jio Platforms (2020), now queued behind India's largest-ever IPO after SEBI's August 2026 clearance, and a $1bn TPG Rise Climate anchor in Tata Passenger Electric Mobility (2021/2023), still six years from a stated but unfiled IPO. Realisation has been the strongest side of the ledger: three full exits in the eighteen months to August 2025, the Shriram General and Life Insurance stakes sold to Sanlam, RR Kabel's final 5% and the whole of Sai Life Sciences (₹2,675 Cr, on top of a June 2025 block), plus Manipal's own partial OFS in August 2026. Set against that, Fractal Analytics, TPG's largest AI-services bet, entered March 2022 at about ₹642/share and priced its February 2026 IPO OFS at just a 9% four-year IRR, with the stock closing its debut day 7% under issue price. The GW read: the financial-services, pharma-CDMO and hospital vintage monetises reliably and re-rates hard, as Manipal shows; the newer pivot into tech-services buy-and-build, AI-services growth and Rise Climate infrastructure is still too young, and in Fractal's case too disappointing, to show whether the same discipline repeats.
Fundraise first: do not underwrite the next vintage until the capital base is visible.
The important signal is not the latest round; it is whether the firm can keep converting marks into distributions.
No named analyst override yet; current view is generated from the scored dossier and should be refreshed when the next primary source lands.
Whether the IIFL Capital Services stake (talks revived Jan 2026) closes, and at what final percentage — reports have ranged from 20% to 40%, still unresolved eight months on.
Financial close and first drawdown on the TCS HyperVault data-centre JV (announced Nov 2025, up to ₹8,820 Cr).
Newer-vintage returns have lagged the pitch: Fractal Analytics' Feb 2026 OFS priced a 9% four-year IRR against an AI-growth thesis, and the stock closed its debut 7% under issue price.
Computed from current dossier sources; analyst override pending.
TPG's India book banked six realisation events in two years, spanning M&A, block sales and two IPOs, more than almost any peer, and Manipal's re-rating from a 2023 recapitalisation to a 2026 IPO is the single best value-creation print on the page. Fractal Analytics' single-digit IRR and a book still built on governance-light minority stakes (Jio, Jana, UPL) keep it short of the top tier.
Graded underPrivate equity rubric v1.0→Board-level access across six-plus portfolio companies (Manipal, Jana, RR Kabel, Sai Life, UPL, Shriram Capital) sits alongside a purely passive 0.93% Jio Platforms stake; majority control only at Altimetrik (60%) and Aseem (100%).
Six dated realisations in the vintage window: Shriram insurance JVs to Sanlam, RR Kabel's final block, Sai Life's full exit (₹2,675 Cr), two IPO OFS (Sai Life, Fractal), and Manipal's Aug 2026 partial OFS at a valuation nearly double its 2023 mark.
Real buy-and-build (Altimetrik-SLK, Aseem's debt-platform scale-up, Manipal's Sahyadri roll-up) sits against Fractal Analytics' 9% IRR undercutting the AI-growth thesis it was bought on.
TPG Asia VIII closed at $5.3bn in May 2024, 14% above its 2018 predecessor, with Rise Climate's Global South Initiative ($1.25bn of a $2.5bn target) and Emerging Companies Asia ($742M) adding fresh India-eligible capital; the IIFL Capital Services talks have run unclosed since January 2026.
Puneet Bhatia has run TPG's India franchise continuously since 2004, with board seats across the core portfolio; the 2023 regional reshuffle (Sarvananthan) left the India team untouched.
Asset quality & control 25% · Exit realisation 30% · Value creation 15% · Capital discipline 15% · Franchise stability 15% — the five contributions above sum to 72. Raw scores compare within private equity; across cohorts compare the tier. See the full GP Score methodology · compare this firm →
Positive catalysts and/or re-up evidence exceed the visible risks, but the score should move only after the named proof lands.
Manipal Health Enterprises liquidity clears with credible OFS/block-sale evidence.
Another senior departure or weak attribution on the next fund's named partners.
Whether the IIFL Capital Services stake (talks revived Jan 2026) closes, and at what final percentage — reports have ranged from 20% to 40%, still unresolved eight months on.
The exit ledger is the diligence file: six dated realisations in two years, cash in hand rather than marks on paper. But price the governance gap: Jio Platforms, Jana and UPL are minority stakes without control, and the newest AI-labelled vintage (Fractal) has already underperformed its own thesis by the only test that counts, a listed IRR.
Newer-vintage returns have lagged the pitch: Fractal Analytics' Feb 2026 OFS priced a 9% four-year IRR against an AI-growth thesis, and the stock closed its debut 7% under issue price.
Whether the IIFL Capital Services stake (talks revived Jan 2026) closes, and at what final percentage — reports have ranged from 20% to 40%, still unresolved eight months on.
Coverage initiated: inaugural GW GP Score.
Catalyst exposure · latest source pressure
Recent public evidence mapped to this GP. Read this before reading the position table: it is where the score can move next.
Keep the file warm; current events cut both ways or are not yet material enough to move score.
Attribution0 positive catalyst(s), 0 pressure catalyst(s); top driver: monthly refresh only.
The funds
$327bn global AUM (30 Jun 2026, +25% YoY) · ~$35bn dedicated Asia-Pacific PE/RE/secondaries platform · India deployment undisclosed in aggregate (GW est. $3.5bn+ since 2015 across disclosed cheques) across 5 tracked vehicles.
| Vehicle | Vintage | Size | Stage | Note |
|---|---|---|---|---|
| TPG Asia VII | 2018Expansion | $4.6bn | Buyout / growth | Backed Sai Life Sciences (fully exited Aug 2025), RR Kabel (fully exited May 2024) and Jana Small Finance Bank. |
| TPG Asia VIII | 2024Recovery / IPO window | $5.3bn | Buyout / growth | Closed 14% above Asia VII; holds the rolled-over 11% Manipal Health Enterprises stake and Altimetrik. |
| TPG Rise Climate | 2022Correction onset | $7.3bn | Climate growth / infrastructure | Flagship vehicle behind the ~$1bn Tata Passenger Electric Mobility anchor (2021/2023). |
| TPG Rise Climate — Global South Initiative | 2024Recovery / IPO window | $1.25bn raised toward a $2.5bn target (Sep 2024) | Climate growth / infrastructure | ~70% Asia-allocated; vehicle for the Aseem Infrastructure Finance buyout and part of the TCS HyperVault stake. |
| TPG Emerging Companies Asia | 2025Recovery / IPO window | $742M raised (Q4 2025) | Mid-cap growth / buyout | New Asia mid-cap strategy; $134M deployed to date; India allocation not yet disclosed (E). |
Closest booksADIA (India) (1 shared) · General Atlantic (1 shared)computed · E
Fund analytics · LP underwriting screen
Computed from the public dossier: vehicle cadence, realised exits, mark drift, concentration and franchise stability. All computed signals are GW estimates.
No fresh flagship close found after the 2021-22 cycle-top window.
Next liquidityManipal Health Enterprises · Tata Passenger Electric Mobility · Jio Platforms
4 visible exit events since Jul 2024.
No fresh flagship close found after the 2021-22 cycle-top window.
5 up / 3 flat / 2 down tracked signals.
No senior departure flagged in key people.
5 up / 3 flat / 2 down
4 events since Jul 2024
Largest tracked active exposure
Higher spread = less balanced franchise
Marked overhangFractal Analytics · Jana Small Finance Bank: names with negative 12-month mark or momentum signals in the reconstructed book.
Rational growth vintages
Exit-led repricing; entry discipline decisive
Repricing began mid-deployment
Exit-led repricing; entry discipline decisive
Listed 5 Aug 2026 (11% premium on debut) after a 29 Jul 2026 pricing at ₹77,607 Cr (India's largest-ever healthcare IPO), following the ₹6,400 Cr Sahyadri Hospitals acquisition (Jul 2025) that pushed the network past 12,000 beds across 49 hospitals. TPG's 11% (unchanged since Temasek's ~$2bn purchase of a 41% slice, Apr 2023) sold only a small tranche in the OFS, trimming rather than exiting.
Tata Motors' EV arm; a further $2bn build-out (new BEV architecture, ten launches) was guided through FY26, with a flagged $1-2bn IPO for FY26-27 not yet filed — TPG's largest single India cheque remains unrealised six years in.
Forced mapping: a diversified telecom/digital-services conglomerate, nearest fit given its network-infrastructure core. Passive, no governance rights; SEBI cleared a ₹37,000 Cr IPO (28 Aug 2026), on track to be India's largest-ever listing — TPG's six-year-old stake is still unmonetised.
At least one cited source is dated 2026.
6 visible events tracked.
10 representative positions tracked.
1 departure signals structured.
Fund-level DPI/TVPI is usually not public; proxy remains estimated.
Peer median 3 · +1
Peer median 2 · +1
Peer median 89 · +2
Peer median 38 · -8
Peer median 0 · +1
Diligence agenda · how this view can change
The live research question, the proof required, and the source standard. This prevents a GP score from becoming a stale label.
Watch is visible in the structured people file; past DPI may not be portable to the next vehicle.
Current · At least one cited source is dated 2026.
Financial close and first drawdown on the TCS HyperVault data-centre JV (announced Nov 2025, up to ₹8,820 Cr).
Confirm partner roster, board attribution and key-man clauses from firm pages, filings, LP memos or named reporting.
Financial close and first drawdown on the TCS HyperVault data-centre JV (announced Nov 2025, up to ₹8,820 Cr).
Manipal Health Enterprises: next public-market or secondary print
Evidence quality · source file health
How hard the public record is beneath this view: source mix, freshness, low-confidence fields and the next source action.
Low-confidence fields: Team data.
32 total sources · 38% primary
At least one cited source is dated 2026.
TPG — TPG Reports Second Quarter 2026 Results (AUM $327bn, 30 Jun 2026)
Upgrade Team data evidence before changing the score.
Source tiering follows Gravitywell policy: primary = filing/regulator/company disclosure, secondary = reputable media or research, E = Gravitywell estimate. Evidence score is a GW control metric, not an external rating.
The position book
Ten live India-linked positions spanning healthcare, fintech, AI services, tech-services buy-and-build and climate/digital infrastructure. Four deals signed since mid-2025 (SCHOTT Poonawalla, SLK Software into Altimetrik, TCS HyperVault, Aseem Infrastructure Finance) have not reached full financial close, and a fifth, IIFL Capital Services, remains in talks.
| Company | Sector | Entered | Entry stage | Status | 12-mo signal | Latest read |
|---|---|---|---|---|---|---|
| Manipal Health Enterprises | Healthcare | 2015 (rolled into TPG Asia VIII, 2023) | Growth buyout via TPG Asia VI, ~₹900 Cr for a significant minority | Public | ▲ | Listed 5 Aug 2026 (11% premium on debut) after a 29 Jul 2026 pricing at ₹77,607 Cr (India's largest-ever healthcare IPO), following the ₹6,400 Cr Sahyadri Hospitals acquisition (Jul 2025) that pushed the network past 12,000 beds across 49 hospitals. TPG's 11% (unchanged since Temasek's ~$2bn purchase of a 41% slice, Apr 2023) sold only a small tranche in the OFS, trimming rather than exiting. |
| Fractal Analytics | AI | Mar 2022 | Growth equity, entered at ~₹642/share via TPG Fett Holdings | Public | ▼ | Listed 16 Feb 2026 at a 2.7% discount to its ₹900 issue price and closed debut day down 7%; TPG sold up to ₹450 Cr of shares in the OFS at a reported 9% four-year IRR and remains the single largest shareholder. |
| Altimetrik (incl. SLK Software) | SaaS & Dev Tools | Jun 2024 | Majority buyout, 60% from founder Raj Vattikuti at a $1.5bn valuation | Private | ▲ | Forced mapping: an AI-first digital-engineering/IT-services platform, not classic SaaS. Bolted on SLK Software for about $600M (signed Jun 2025), taking the combined group toward a $1bn revenue target on an 80%-plus India workforce. |
| Aseem Infrastructure Finance | EV & Climate | Jul 2026 | 100% buyout via TPG Rise Climate's Global South Initiative, with GIC and ICICI Bank (up to 5%) co-investing | Private | ▲ | Acquired from NIIF for a reported ~₹4,000 Cr; the renewable-energy and power-transmission debt platform has disbursed over ₹40,000 Cr financing 27+ GW of projects. |
| Tata Passenger Electric Mobility | EV & Climate | 2021 (closed Jan 2023) | TPG Rise Climate-led $1bn for an 11-15% consortium stake at up to $9.1bn valuation | Private | → | Tata Motors' EV arm; a further $2bn build-out (new BEV architecture, ten launches) was guided through FY26, with a flagged $1-2bn IPO for FY26-27 not yet filed — TPG's largest single India cheque remains unrealised six years in. |
| TCS HyperVault | Logistics & Infra | Nov 2025 | Strategic JV via Rise Climate's Global South Initiative + TPG Asia Real Estate, up to ₹8,820 Cr for a 27.5-49% stake | Private | → | Forced mapping: TCS brands this an 'AI data centre' business, but the underlying asset is physical infrastructure capacity, part of a ₹18,000 Cr ($2bn+) combined build plan. Signed; financial close not confirmed as of this vintage. |
| Jio Platforms | Logistics & Infra | 2020 | ₹4,546.80 Cr for 0.93% (part of Reliance's $20bn+ 2020 stake-sale round) | Private | ▲ | Forced mapping: a diversified telecom/digital-services conglomerate, nearest fit given its network-infrastructure core. Passive, no governance rights; SEBI cleared a ₹37,000 Cr IPO (28 Aug 2026), on track to be India's largest-ever listing — TPG's six-year-old stake is still unmonetised. |
| SCHOTT Poonawalla | Healthcare | May 2025 | Minority buy-in, 35% from Serum Institute of India, with Novo Holdings co-investing | Private | ▲ | SCHOTT Pharma retains 50% of the pharma-glass-packaging JV and SII keeps a minority slice; deal run through TPG Growth, financial terms undisclosed. |
| Jana Small Finance Bank | Fintech | 2014 (as Janalakshmi Financial Services) | Growth / structured equity via TPG Asia VI SF | Public | ▼ | TPG holds 8.11%; reports (May 2026) said it may pare a further 5% as the promoter looks to raise equity, against an industry-wide FY25-26 microfinance asset-quality downcycle. Outcome of that reported sale unconfirmed as of this vintage. |
| UPL Corporation | Consumer & Commerce | 2018 (closed Jan 2019) | Structured minority co-investment, $600M for ~11% alongside ADIA's matching $600M | Private | → | Forced mapping: the global crop-protection/agrochemicals platform (funding UPL's $4.2bn Arysta acquisition) has no dedicated agri-inputs bucket in the taxonomy. A 2023-vintage ₹1,580 Cr add-on (with ADIA and Brookfield) went into UPL Sustainable Agri Solutions, the India platform then valued at ₹17,380 Cr. |
Representative tracked positions reconstructed from public disclosures: not the full book. 12-mo signal is a GW estimate of mark direction from round/exit prints (E). Ownership stakes are not shown: not reliably public.
Sector exposure · where the book leans
Share of the tracked active book by normalized sector (GW estimate): read against our sector dossiers for crowding.
New cheques · 2025-26
TPG's FY25-26 India dealbook runs on two tracks: TPG Rise Climate writing cheques into hard and digital infrastructure (Aseem's renewable-debt book, the TCS HyperVault data-centre JV) while TPG Capital and TPG Growth keep building services and healthcare platforms (SLK Software into Altimetrik, SCHOTT Poonawalla, the still-unsigned IIFL Capital talks). None of the four deals signed since mid-2025 has reached full financial close and cash deployment as of this vintage.
TPG Rise Climate leads, with GIC and ICICI Bank (up to 5%) co-investing; acquired from NIIF.
TPG committing up to ₹8,820 Cr of a ₹18,000 Cr combined build plan for AI-ready data-centre capacity.
Reported deal value ₹3,636-4,848 Cr ($404-539M); would trigger a mandatory 26% open offer; still not signed as of this vintage, eight months after talks resumed.
Folded into TPG-controlled Altimetrik to build an AI-first engineering-services group.
Bought from Serum Institute of India via TPG Growth; Novo Holdings co-invested.
Realisation · are LPs getting paid?
Six dated realisations in under two and a half years, across every channel PE uses: strategic sale (Shriram insurance JVs to Sanlam, April 2024), block sales (RR Kabel's final stake, Sai Life's remaining stake) and two IPO OFS events (Sai Life December 2024, Fractal Analytics February 2026), plus Manipal Health Enterprises' August 2026 partial OFS at a valuation nearly double its April 2023 mark. The one soft data point, Fractal's 9% four-year IRR, is also the one full-cycle test of TPG's newest, AI-labelled vintage.
TPG India Investments sold its 6.29% (SGIC) and 7.04% (SLIC) stakes to South Africa's Sanlam, exiting the Shriram Group insurance JVs after a relationship dating to 2008; Sanlam's combined economic holdings rose to 50.99% (SGIC) and 54.4% (SLIC).
TPG Asia sold its final ~5% (₹958 Cr, 21 tranches at an average ₹1,701/share) via open-market transactions, completing a full exit from the wires-and-cables maker roughly eight months after its September 2023 IPO, at which TPG had already sold the bulk of its holding.
The ₹3,042 Cr IPO's offer-for-sale cut TPG's pre-IPO stake (undisclosed original size, from a Jul 2018 minority acquisition) to a reported 24.73% as of March 2025.
TPG sold its remaining stake, reported as 14.7%, for ₹2,675 Cr across three tranches (₹871.01-871.86/share), completing a full exit on top of a ₹1,505 Cr block in June 2025 to Nippon India MF, BlackRock and others (reported tranche percentages do not cleanly reconcile across sources; total cash realised across the 2025 window is ~₹5,000 Cr).
Partial OFS in the ₹2,833.9 Cr IPO; TPG (via TPG Fett Holdings) realised a reported 9% four-year IRR on its March 2022 entry as shares listed at a 2.7% discount to the ₹900 issue price.
TPG SG Magazine sold a tranche of shares in India's largest-ever healthcare IPO OFS (₹9,275 Cr issue, ₹560-590 band, ₹77,607 Cr valuation, listed 5 Aug at an 11% premium); a partial trim, not a full exit — TPG's residual 11% continues post-listing.
Remaining stake sold Aug 2025, eight months post-IPO; full realisation of a Jul 2018 minority entry (on top of a ₹1,505 Cr June 2025 block).
Valuation nearly doubled between the Apr 2023 Temasek recapitalisation and the Jul 2026 IPO pricing; TPG's 11% (unchanged since 2023) rode the re-rating almost untouched.
TPG's realised return on its Feb 2026 partial exit across a four-year hold; the stock closed 7% under issue price on debut.
Closed May 2024, 14% above predecessor TPG Asia VII's $4.6bn (2018): an LP-demand signal for the regional platform India sits inside.
The realisation engine and the deployment engine tell different stories. Six clean, dated exits in under two and a half years sit against a fresh $5.3bn TPG Asia VIII (May 2024) and five India commitments signed since mid-2025 (SCHOTT Poonawalla, Altimetrik-SLK, TCS HyperVault, Aseem, the still-unsigned IIFL Capital talks), most not yet at full cash deployment. Manipal's re-rating is the standout value-creation print on the page; Fractal Analytics' 9% IRR is the standout caution. E.
What they're doing
Anchor large, control-oriented buyouts in healthcare and financial services, then re-lever ownership through fund-to-fund rolls (Manipal: TPG Asia VI into TPG Asia VIII) rather than exiting on a fixed schedule.
Run buy-and-build consolidation in tech services — Altimetrik's ~$600M SLK Software bolt-on is the template for a $1bn-revenue AI-engineering platform.
Route India climate and digital infrastructure (Aseem, TCS HyperVault, the older Tata Passenger Electric Mobility stake) through TPG Rise Climate, keeping climate-labelled and infra bets off the flagship Asia buyout fund.
Monetise opportunistically into India's open IPO window: three full exits (Shriram insurance, RR Kabel, Sai Life Sciences) realised in 18 months to Aug 2025, then a partial Manipal OFS a year later.
What can break
Newer-vintage returns have lagged the pitch: Fractal Analytics' Feb 2026 OFS priced a 9% four-year IRR against an AI-growth thesis, and the stock closed its debut 7% under issue price.
The two largest live commitments, the ₹3,636-4,848 Cr IIFL Capital Services stake and the TCS HyperVault data-centre JV, are still in diligence or signed-but-not-closed as of this vintage, so headline deployment figures are not yet cash-in.
TPG's oldest and largest single trophy stakes (Jio Platforms' 0.93%, Tata Passenger Electric Mobility's $1bn) carry no governance rights and, six years and three years in respectively, no realisation event yet — even as Jio's IPO window opens.
Whether the IIFL Capital Services stake (talks revived Jan 2026) closes, and at what final percentage — reports have ranged from 20% to 40%, still unresolved eight months on.
Financial close and first drawdown on the TCS HyperVault data-centre JV (announced Nov 2025, up to ₹8,820 Cr).
Jio Platforms IPO pricing and TPG's participation once dates are set — the first real test of whether the 2020 passive stake converts to cash.
Jana Small Finance Bank: whether TPG's reported 5% pare-down (flagged for announcement 18 May 2026) actually completed.
Point-in-time discipline: these are the open items we could not verify at the current vintage. They get resolved: confirmed, corrected or dropped, at the next monthly refresh, never silently.
The takes · one screen, three readers
The exit ledger is the diligence file: six dated realisations in two years, cash in hand rather than marks on paper. But price the governance gap: Jio Platforms, Jana and UPL are minority stakes without control, and the newest AI-labelled vintage (Fractal) has already underperformed its own thesis by the only test that counts, a listed IRR.
TPG's Rise Climate playbook puts equity cheques into infrastructure platforms (Aseem, TCS HyperVault) rather than operating companies, and it is the template worth copying for India's climate and AI-data-centre buildout: it converts capex-hungry corporates into fee-earning platforms without an operating turnaround.
Watch Jio Platforms' IPO as a systemic signal: TPG's six-year-old, wholly passive stake is a proxy for how India's largest pre-IPO trophy names finally price. Manipal's near-doubling into its 2026 listing is the healthcare-sector re-rating benchmark.
Sourcing. Every figure is sourced and dated. We tier provenance: Primary (official, regulatory, exchange or company filings), Secondary (tier-1 industry research and reputable media), and GW estimate (our own reconstruction or opinion, labelled, never presented as external fact). We prefer primary where it exists, reconcile divergent prints to cited ranges, and hold every number point-in-time: dated, and never silently restated; revisions publish as dated changes.
Fact vs opinion. Facts vs opinion: market sizes, official prints, prices, named deals and agency ratings are sourced facts (Primary/Secondary). Scores, grades, purity weights, scenario paths and indicative sparkline points are Gravitywell's analytical opinion (GW estimate): labelled, not presented as external data.
GW GP Scores are research opinions, not investment advice, not a solicitation, and not an assessment under any SEBI regulation. Dossiers are compiled from public sources believed reliable; firms named did not participate and figures marked E are Gravitywell estimates. Point-in-time: dated to the vintage shown and never silently restated.